New CEO at BioCeramic Therapeutics
This article was originally published in Scrip
Executive Summary
BioCeramic Therapeutics, a UK company focused on the field of biomaterials for healthcare, has named Ian Brown chief executive officer. The appointment is part of a succession plan that was developed by the company's board of directors over the past six months for its CEO position, which will see Daniel Green, BioCeramic's outgoing founding CEO, remain as a director. Mr Brown has previously held senior executive positions at Chromogenix, Instrumentation Laboratory, Cordlife, SDP Technology and Avanti Capital.